Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pasireotide in the Personalized Treatment of Acromegaly.
Puig-Domingo M, Bernabéu I, Picó A, Biagetti B, Gil J, Alvarez-Escolá C, Jordà M, Marques-Pamies M, Soldevila B, Gálvez MA, Cámara R, Aller J, Lamas C, Marazuela M. Puig-Domingo M, et al. Front Endocrinol (Lausanne). 2021 Mar 16;12:648411. doi: 10.3389/fendo.2021.648411. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33796079 Free PMC article. Review.
Expert document on management of acromegaly.
Bernabeu I, Cámara R, Marazuela M, Puig Domingo M. Bernabeu I, et al. Endocrinol Diabetes Nutr (Engl Ed). 2018 Oct;65(8):428-437. doi: 10.1016/j.endinu.2018.05.012. Epub 2018 Jul 4. Endocrinol Diabetes Nutr (Engl Ed). 2018. PMID: 30244765 English, Spanish.
Molecular profiling for acromegaly treatment: a validation study.
Puig-Domingo M, Gil J, Sampedro-Nuñez M, Jordà M, Webb SM, Serra G, Pons L, Salinas I, Blanco A, Marques-Pamies M, Valassi E, Picó A, García-Martínez A, Carrato C, Buj R, Del Pozo C, Obiols G, Villabona C, Cámara R, Fajardo-Montañana C, Alvarez CV, Bernabéu I, Marazuela M. Puig-Domingo M, et al. Endocr Relat Cancer. 2020 Jun;27(6):375-389. doi: 10.1530/ERC-18-0565. Endocr Relat Cancer. 2020. PMID: 32302973
Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas.
Gil J, Marques-Pamies M, Jordà M, Fajardo-Montañana C, García-Martínez A, Sampedro M, Serra G, Salinas I, Blanco A, Valassi E, Sesmilo G, Carrato C, Cámara R, Lamas C, Casano-Sancho P, Alvarez CV, Bernabéu I, Webb SM, Picó A, Marazuela M, Puig-Domingo M; on behalf REMAH investigators. Gil J, et al. Clin Endocrinol (Oxf). 2021 May;94(5):811-819. doi: 10.1111/cen.14339. Epub 2021 Mar 14. Clin Endocrinol (Oxf). 2021. PMID: 32978826
41 results